Large-scale testing (Phase 3)Study completedNCT01131676
What this trial is testing
BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).
Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 7,064